FDA Inspection 1279102 — Kaohinani Longwolf, MD

Kaohinani Longwolf, MD — FEI 3038623204

The FDA completed an inspection of Kaohinani Longwolf, MD on August 13, 2025 in Salt Lake City, UT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 13, 2025
Fiscal Year
2025
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Salt Lake City, UT (United States)

Additional Details

Clinical Investigator (CI)